|
End-of-day quote
Shanghai S.E.
2026-09-16
|
5-day change | 1st Jan Change | ||
| 8.770 CNY | +0.92% |
|
-6.60% | -9.59% |
| 08-27 | Sinotherapeutics Inc. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 04-29 | Sinotherapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 3.94B 587M 509M 481M 437M 818M 56.32B 823M 5.74B 2.22B 28.57B 2.21B 2.16B 91.05B | P/E 2024 |
35.9x | P/E 2025 | 88.2x |
|---|---|---|---|---|---|
| Enterprise Value | 3.19B 476M 412M 390M 354M 663M 45.64B 667M 4.65B 1.8B 23.15B 1.79B 1.75B 73.79B | EV / Sales 2024 |
7.4x | EV / Sales 2025 | 8.08x |
| Free-Float |
24.34% | Yield 2024 |
0.62% | Yield 2025 | 0.36% |
| 1 day | +0.92% | ||
| 1 week | -6.60% | ||
| Current month | -4.36% | ||
| 1 month | -18.65% | ||
| 3 months | +11.29% | ||
| 6 months | -9.77% | ||
| Current year | -9.59% |
| 1 week | 8.43 |  | 9.18 |
| 1 month | 8.43 | | 11.18 |
| Current year | 7.02 | | 11.33 |
| 1 year | 7.02 | | 11.46 |
| 3 years | 6.3 | | 14 |
| 5 years | 6.3 | | 28 |
| 10 years | 6.3 | | 28 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ming Jie Guo
CEO | Chief Executive Officer | 53 | 2023-04-05 |
Yi Ming Wu
DFI | Director of Finance/CFO | 57 | 2025-04-29 |
Hui Zhang
IRC | Investor Relations Contact | 44 | 2023-05-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Jun Ye
CHM | Chairman | 53 | 2020-08-17 |
Xiao Ming Ying
BRD | Director/Board Member | 58 | 2012-07-31 |
Si Yu Shen
BRD | Director/Board Member | 44 | 2018-08-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.92% | -6.60% | -20.92% | -21.77% | 581M | |
| +1.01% | -1.72% | +15.70% | +61.20% | 45.9B | |
| -4.55% | -7.58% | +28.20% | +96.63% | 38.7B | |
| +0.77% | -3.32% | +6.81% | +71.61% | 11.43B | |
| +0.52% | -1.88% | -12.29% | +9.92% | 11.38B | |
| +0.77% | +0.77% | +20.74% | +148.34% | 9.09B | |
| -0.47% | +0.16% | +27.34% | +36.14% | 7.3B | |
| +1.61% | -2.61% | +14.79% | +181.38% | 6.98B | |
| -1.00% | -3.90% | +34.92% | -20.68% | 7.13B | |
| +0.61% | -4.18% | -43.92% | +5.23% | 4.89B | |
| Average | -0.03% | -1.89% | +7.14% | +56.80% | 14.34B | |
| Weighted average by Cap. | -0.75% | -2.56% | +15.79% | +71.31% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 512M 76.28M 66.1M 62.48M 56.72M 106M 7.32B 107M 746M 288M 3.71B 287M 280M 11.83B | 447M 66.58M 57.7M 54.53M 49.51M 92.79M 6.39B 93.34M 651M 252M 3.24B 250M 245M 10.33B |
| Net income | 128M 19.04M 16.5M 15.59M 14.16M 26.53M 1.83B 26.69M 186M 71.93M 926M 71.52M 69.93M 2.95B | 47.48M 7.08M 6.13M 5.8M 5.26M 9.87M 679M 9.92M 69.22M 26.75M 344M 26.59M 26M 1.1B |
| Net Debt | -734M -109M -94.77M -89.57M -81.32M -152M -10.49B -153M -1.07B -413M -5.32B -411M -402M -16.96B | -746M -111M -96.44M -91.15M -82.75M -155M -10.68B -156M -1.09B -420M -5.41B -418M -409M -17.26B |
Employees
319
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-15 | CN¥8.770 | +0.92% | 3,534,530 |
| 26-09-15 | CN¥8.690 | -1.70% | 3,779,854 |
| 26-09-14 | CN¥8.840 | +3.27% | 3,104,143 |
| 26-09-11 | CN¥8.560 | -3.82% | 5,106,003 |
| 26-09-10 | CN¥8.900 | -3.99% | 4,021,810 |
- Stock Market
- Stocks
- 688247 Stock
Select your edition
All financial news and data tailored to specific country editions
